UofG Profile
​facebook.com/HelgasonLab
​
In 2013, following successful Fellowship applications, Professor Vignir Helgason relocated from the Paul O’Gorman Leukaemia Research Centre to the recently opened world-class Wolfson Wohl Cancer Research Centre to setup his own research group “Leukaemia and Autophagy Therapeutics”. Recently his laboratory has, in collaboration with Cancer Metabolism Research Unit at the Cancer Research UK Beatson Institute, optimised protocols for metabolic assays using rare stem cells and already identified targetable metabolic dependencies in chronic myeloid stem cells. The Howat Foundation has supported the group and this research theme. The support will allow the team to appoint more staff to test promising drugs and further support the search for metabolic abnormalities in other stem cell driven leukaemias, such as acute myeloid leukaemia, where improved therapy options are urgently needed.
​